Knowledge and Attitudes of Licensed Canadian Healthcare Providers on Cannabis Use During Pregnancy
Summary
This study consists of a short online survey for licensed healthcare providers in Canada to assess their knowledge and attitudes about cannabis use during pregnancy. We want to understand what healthcare providers know about the impacts of cannabis use during pregnancy and their awareness of guidelines, as well as their attitudes towards pregnant people who use cannabis. By learning more about providers' knowledge and attitudes, we hope to find ways to improve education, support, and care for pregnant people.
Eligibility
Eligible ages: 18 to 80
Accepts healthy participants: Yes
Inclusion criteria:
Licensed healthcare providers (physicians, nurses, midwives, lactation consultants, physical therapists, occupation therapists) who:
1) actively practice in Canada
2) practice in perinatal health
3) able to read and respond to a survey in English
Exclusion criteria:
You are not eligible to participate if you:
1) Retired or non-practicing
2) A student or trainee who is not currently licensed
3) Are not involved in perinatal care
Participate
Fill out the following form if you want to participate in this research
UCalgary Notice of Collection
The University of Calgary (UCalgary) respects your privacy and is
committed to ensuring the privacy of all students, staff, and community members. Your personal information is being
collected under the authority of section 4(c) of the Protection of Privacy Act (POPA). It will be collected, used
and disclosed for the purposes outlined in UCalgary’s
Notice of
Collection, Use and Disclosure of Personal Information and managed in accordance with UCalgary’s
Privacy
Management Program.
Your personal information may be input into automated systems to generate content or make decisions,
recommendations, or predictions. If you have questions regarding this notice or UCalgary’s collection,
use, or disclosure of your personal information, please contact
accessandprivacy@ucalgary.ca.
Additional information
Contact information
If you would like more information or to participate in the research please contact the researcher at the email address provided.
Principal investigator:
Meredith Brockway
Clinical trial:
No
REB-ID:
REB25-1356